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 9 
Abstract 10 
Metabolism of dietary glycans is pivotal in shaping the human gut microbiota. The mechanisms that 11 
promote competition for glycans amongst gut commensals, however, remain unclear. Roseburia 12 
intestinalis, an abundant butyrate-producing Firmicute, is a key degrader of the major dietary fiber 13 
xylan. Despite the association of this taxon to a healthy microbiota, insight is lacking into its glycan 14 
utilization machinery. Here, we investigate the apparatus that confers R. intestinalis growth on 15 
different xylans. R. intestinalis displays a large cell-attached modular xylanase that promotes 16 
multivalent and dynamic association to xylan via three known and one novel xylan-binding module. 17 
This xylanase operates in concert with an ATP-binding cassette (ABC) transporter to mediate break-18 
down and selective internalization of xylan-fragments. This apparatus supports co-growth between 19 
R. intestinalis with a model xylan-degrading Bacteriodes in mixed cultures. The transport protein of 20 
R. intestinalis prefers xylo-oligosaccharides of 4−5 xylosyl-units, whereas the counterpart from 21 
competing Bacteroides targets larger ligands.  This insight highlights the differentiation of capture 22 
and transport preferences as a strategy to facilitate co-growth on abundant dietary fibers by gut 23 
commensals. These findings offer a unique route to manipulate the microbiota based on glycan-24 
transport preferences in therapeutic interventions to boost or restore distinct taxa.  25 
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Introduction  26 
The human gut microbiota (HGM) is recognized as a determinant of human health and metabolic 27 
homeostasis1,2. Specific signatures of the HGM are associated with local and systemic disorders 28 
including irritable-bowel disease, obesity, type 2 diabetes and colon cancer3. The composition of the 29 
HGM is greatly affected by dietary glycans, which are non-digestible by the host4,5. Only a few 30 
species out of the hundreds present in the HGM are equipped to deconstruct distinct complex 31 
polysaccharides and ferment them into short chain fatty acids (SCFAs)6. The impact of SCFAs on host 32 
health and physiology remains an important aspect of the microbiota-host interaction. Particularly 33 
the SCFA butyrate, the preferred energy source for colonocytes, is known to have anti-inflammatory 34 
roles and reduce the risk of colon cancer and enteric colitis7–10. Butyrate producers belonging to the 35 
Firmicutes phylum are generally abundant in healthy individuals, but are markedly reduced in 36 
patients with inflammatory disorders11,12. Butyrate producers including Roseburia spp. are increased 37 
in metabolic syndrome patients after faecal transfer therapy, and  correlate positively to 38 
improvement of insulin resistance13. Investigations of the metabolic preferences of butyrate 39 
producers and their interplay with major HGM commensals are instrumental to develop therapeutic 40 
interventions targeting butyrate-deficiency related disorders. 41 
Roseburia is a common genus of Clostridium cluster XIVa within the Firmicutes that harbours 42 
prevalent butyrate producers14,15. This taxon adheres to mucin, consistent with an intimate 43 
association with the host16. Roseburia intestinalis strains encode an impressive repertoire of 44 
carbohydrate active enzymes (CAZymes) compared to most other Firmicutes17. R. intestinalis, the 45 
taxonomically related Eubacterium rectale and species from the Bacteroides genus are the only 46 
known HGM taxa  that utilize the major hemicellulosic polysaccharide xylan18–20. Xylan is particularly 47 
abundant in cereal grains (arabinoxylan, AX), but is also found in fruits and vegetables 48 
(glucuronoxylan, GX)21 (Fig. 1a). Xylan utilization by dominant gut commensals belonging to the 49 
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Bacteriodes genus has been investigated in detail22,23, but similar knowledge is lacking for Firmicutes 50 
counterparts.  51 
Here, we show that Roseburia intestinalis L1-82 grows on acetyl, arabinosyl and 4-O-methyl-52 
glucuronosyl decorated dietary-relevant xylans, with a preference for cereal arabinoxylans. The 53 
growth is mediated by a multi-modular cell-attached xylanase and by an ABC transporter. The gene 54 
encoding this transporter was the most upregulated in response to xylan, consistent with a 55 
paramount role during growth on this glycan. We have characterized the xylanolytic enzymes and 56 
the transport protein, which enabled modelling xylan utilization by R. intestinalis and the 57 
identification of two novel xylan-specific CAZyme families. R. intestinalis efficiently competes with a 58 
model xylan degrader belonging to the genus Bacteroides, when grown on soluble and insoluble 59 
xylans. A striking finding was that the transport proteins that confer xylo-oligosaccharides capture in 60 
R. intestinalis and Bacteroides targeted ligands of different sizes, thus markedly reducing the 61 
competition for preferred ligands by either taxon. These results emphasize the competitiveness of 62 
butyrate producing Firmicutes in targeting key dietary fibers like xylan. The substantial differences in 63 
transport proteins highlight the differential capture and transport preference as a key feature to 64 
facilitate co-growth on abundant dietary fibres such as xylan. 65 
 66 
Results  67 
Inducible cell-attached xylanase activity mediates growth of R. intestinalis on substituted xylans 68 
Anaerobic growth of R. intestinalis L1-82 was measured as an increase in OD600 nm for growth on 69 
soluble xylans and as a decrease in pH for growth on insoluble xylans (Fig. 1b-d). R. intestinalis L1-82 70 
grows rapidly on soluble xylans with a preference for wheat arabinoxylan (WAX, µmax=0.26 h-1) 71 
compared to birch glucuronoxylan (BGX, µmax=0.13 h-1) (Fig. 1c). Interestingly, this bacterium also 72 
utilizes highly acetylated xylans and insoluble cereal arabinoxylans from wheat (InWAX) and oat 73 
spelt (OSX), but not cornbran glucuronoarabinoxylan (CBX). Xylo-oligosaccharides and xylan-derived 74 
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monosaccharides (except glucuronic acid) were also utilized (Fig. 1b). Extracellular endo-1,4-β-75 
xylanase (hereafter referred to as xylanase) activity was induced upon growth on BGX, WAX, and 76 
xylobiose (X2), despite poor growth on the latter disaccharide (Fig. 1e). The xylanase activity was 77 
cell-attached, but was released upon treatment of the cells with a high salt concentration (Fig. 1f), 78 
suggesting noncovalent attachment. 79 
  80 
Genes encoding an ABC transporter and a multi-modular xylanase are amongst the top 81 
upregulated in response to growth of R. intestinalis on xylan 82 
To elucidate the genetic basis for growth on xylans, we performed an RNA-seq transcriptional 83 
analysis of R. intestinalis grown on WAX, BGX, xylose and glucose. Of the 4777 predicted genes, 1‒84 
3.5% were highly upregulated (Log2 fold-change > 5) on xylans compared to glucose (Supplementary 85 
Table 1), the majority being involved in carbohydrate and energy metabolism. Besides a separate 86 
locus encoding a multi-modular xylanase of glycoside hydrolase family 10 (GH10 according to the 87 
CAZy classification, http://www.cazy.org24), the top genes in the xylan transcriptomes cluster on a 88 
single locus (Fig. 2a,b). This locus contains eleven genes including four xylanolytic CAZymes of GH43, 89 
GH115, GH8, GH3. Only one (ROSINTL182_08192, LacI type, Pfam 00356) of three transcriptional 90 
regulator genes was highly upregulated. Strikingly, the most upregulated gene in the xylan 91 
transcriptomes encodes a solute binding protein (SBP) of an ABC transporter. Furthermore, the 92 
genes encoding the permease components of this ABC transporter were amongst the top six 93 
upregulated by xylans. Signal peptides were only predicted for the xylanase and the transporter SBP, 94 
consistent with extracellular breakdown of xylan followed by capture and uptake of xylo-95 
oligosaccharides by the ABC transporter. The expression and the localization of the transport SBP 96 
and the xylanase at the cell surface were corroborated using immunofluorescence microscopy (Fig. 97 
2c). Two additional loci, unique to R. intestinalis L1-82, lacking in other R. intestinalis strains, were 98 
also upregulated albeit markedly less (Supplementary Fig. 1a-d). One of these loci encodes a second 99 
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cell attached GH10 xylanase, which is also expressed at the cell surface (Supplementary Fig. 1e). The 100 
transcriptomic analysis also enabled us to assign the ABC-transporter mediating xylose import and to 101 
outline the genes involved in intracellular metabolism of xylose, arabinose and glucuronic acid 102 
(Supplementary Fig. 1f,g).   103 
 104 
A new family of binding modules confers extended and dynamic xylan binding to the multi-105 
modular xylanase in R. intestinalis  106 
The highly upregulated RiXyn10A, which is conserved within the R. intestinalis species, is one of the 107 
largest known xylanases from human gut bacteria (Supplementary Fig. 2b). RiXyn10A comprises an 108 
N-terminal unassigned domain (residues 28−165), a xylan binding module of CBM22, a catalytic 109 
module of GH10, a tandem repeat of CBM9 xylan binding modules, a bacterial Ig-like domain group 2 110 
(BIG2, pfam02368)25 and a Listeria-Bacteroides repeat domain (LBR, pfam09479)26. The two latter 111 
domains likely mediate cell attachment of the enzyme to the cell25–27 in accordance with their 112 
positive charge, which is compatible with binding to the negatively charged cell surface (residues 113 
1100-1356, pI>10).  114 
To generate insight into the unique modularity of RiXyn10A, we characterized the enzyme and 115 
truncated versions thereof (Fig. 3a-d). RiXyn10A incubated with BGX, WAX and InWAX generated 116 
linear and decorated oligosaccharides (Fig. 3b,c and Fig. 4). RiXyn10A was inactive on highly and 117 
heterogeneously substituted arabinoglucuronoxylan from corn bran, consistent with the lack of 118 
growth on this substrate by R. intestinalis. The enzyme was inactive on xylobiose (X2) and showed 119 
very low activity on xylotriose (X3) (Supplementary Fig. 3a). By contrast, xylotetraose (X4) and 120 
xylopentaose (X5) were hydrolyzed stoichiometrically, revealing the requirement for at least four 121 
substrate-binding sub-sites for efficient hydrolysis.  122 
A BLASTP search of the N-terminal unassigned domain (CBMx) against UniProt gave no hits 123 
indicating the lack of homologues with assigned function. CBMx confers affinity to xylan as implied 124 
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from a two times higher KM when this domain was deleted (Fig. 3d). Affinity electrophoresis 125 
established CBMx to be a novel xylan-binding module and revealed a 30-fold stronger binding for 126 
WAX compared to BGX (Fig. 3e,f and Supplementary Fig. 3c). Surface plasmon resonance (SPR) 127 
analysis revealed the highest affinity towards xylohexaose (X6) consistent with the presence of a 128 
binding cleft large enough to accommodate at least six xylosyl units (Fig. 3e,g and Supplementary 129 
Fig. 4a-e). This analysis also indicated specificity to xylan as there was no measurable affinity to 130 
mannohexaose (Man6). The relatively low binding affinity to X6 (KD≈0.5 mM) was corroborated using 131 
isothermal titration calorimetry (ITC) (Fig. 3e and Supplementary Fig. 4g,f). Deleting CBMx decreased 132 
the average KD of RiXyn10A from 128 µM to 65.4 µM (RiXyn10A∆CBMx) (Fig. 3e and Supplementary 133 
Fig. 4h-k), asserting that at least one or more of other CBMs possess higher affinity compared to the 134 
N-terminal new module. Homologues (sequence identity 55−27%) of the new CBM are present 135 
mainly in other bacteria from Clostridium XIVa cluster (Supplementary Fig. 4l), which merits the 136 
assignment of these modules into a new CBM family.  137 
 138 
Preference of the binding protein of the ABC transporter that mediates uptake of xylan oligosaccharides in R. 139 
intestinalis 140 
We showed above that the action of xylanases produces complex xylo-oligosaccharides likely decorated with 141 
arabinosyl and 4-O-methyl-glucuronosyl. The presence of these decorations is supported by the decrease in 142 
some of these peaks and the increase in arabinose and un-substituted xylo-oligosaccharides after treatment with 143 
debranching enzymes (see next section). No oligosaccharides were detectable (HPAEC-PAD analysis, data not 144 
shown) in spent supernatants from R. intestinalis growth on xylan, suggesting efficient uptake of oligomeric 145 
products. The transcriptional analysis (Fig. 2a) identified an ABC transporter likely to mediate the uptake of the 146 
xylo-oligosaccharides hydrolysis products of RiXyn10A from WAX and BGX. The preference of SBPs associated 147 
with oligosaccharide-specific ABC transporters has been shown to correlate well to the uptake preference of 148 
bacteria28,29. We measured the affinity of RiXBP, the SBP of the upregulated ABC transporter, on a range of xylo-149 
oligosaccharide ligands (Table 1 and Supplementary Fig. 5). The preferred un-substituted ligand was X5 150 
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followed by X4, and the affinity decreased steeply for smaller or larger oligosaccharides. Internal 151 
arabinosyl decorations (AX4) appeared to be preferred based on the 2.4-times higher affinity 152 
compared to the un-substituted X4. The tolerance and recognition of arabinosylated ligands is in 153 
agreement with the good growth on WAX. These results suggest that RiXBP is selective in capturing 154 
internally branched xylo-oligosaccharides with a xylose backbone of 4−5 xylose residues. 155 
 156 
R. intestinalis degrades internalized decorated xylo-oligosaccharides by the concerted action of 157 
three hydrolases and a novel family of acetyl esterases 158 
Xylo-oligosaccharides are degraded in the cytoplasm after their uptake. To gain insight into 159 
intracellular xylan-oligosaccharide breakdown, we produced and characterized the α-glucuronidase 160 
RiAgu115A (GH115), the α-L-arabinofuranosidase RiAbf43A (GH43), two xylosidases RiXyl8 (GH8) and 161 
RiXyl3A (GH3) as well as RiAXE (ROSITNL182_08194, GenBank accession EEU99941.1) from the core 162 
xylan utilization locus.  163 
RiAgu115A released 4-O-methyl-glucuronic acid (MeGlcA) from glucuronoxylans (BGX and BeGX) and 164 
from BGX pretreated with RiXyn10A (Fig. 4a and Supplementary Fig. 6a-c). The kcat/KM of RiAgu115A 165 
was 16-fold higher on glucuronoxylan hydrolysate compared to intact glucuronoxylan 166 
(Supplementary Fig. 6c), indicating that RiAgu115A preferentially accommodates glucuronoxylo-167 
oligosaccharides, consistent with the intracellular localization of this enzyme. This enzyme also 168 
cleaves MeGlcA decorations at the xylosyl penultimate to the reducing end (generated using a GH30 169 
glucuronoxylanase, Supplementary Fig. 6b), but its activity was blocked by the presence of 170 
acetylations (Fig. 4d).   171 
RiAbf43A is an α-L-arabinofuranosidase that exclusively releases arabinose from WAX (Fig. 4a). 172 
Kinetic analysis towards WAX and arabino-xylotetraose (AX4) (Supplementary Fig. 6d) revealed 173 
recognition of internal arabinosyl substitutions, with a 13-fold increase in kcat for oligosaccharides 174 
consistent with the intracellular localization. 175 
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Both RiXyl8 and RiXyl3A generated xylose from xylo-oligosaccharides, but lacked activity towards 176 
xylan (Supplementary Fig. 6g-k). RiXyl3A degraded xylo-oligosaccharides completely into 177 
monosaccharides, while RiXyl8 was inactive towards X2. Reduction of xylo-oligosaccharides with 178 
NaBH4 abolished the activity of RiXyl8 assigning it as a reducing-end β-xylosidase30 (Supplementary 179 
Fig. 6i), in contrast to RiXyl3A that recognizes non-reducing xylosyl moieties and maintains activity 180 
on reduced xylo-oligosaccharides. Thus, the concerted and overlapping activities of these enzymes 181 
(Supplementary Fig. 6) results in rapid depolymerization of arabinosyl and MeGlcA decorated xylo-182 
oligosaccharides.   183 
RiAXE, which was un-assigned, based on lack of hits in a BLASTP search of UniProt, was highly 184 
upregulated on xylans (Fig. 2a). This enzyme possesses the conserved residues in the SGNH lipases-185 
esterases superfamily (Pfam cd00229), which also includes CAZy carbohydrate esterase families CE2, 186 
CE3, CE12 and CE16.  We established that RiAXE is an acetyl esterase, but low sequence identities to 187 
these families (<12%) merit assigning RiAXE into a new carbohydrate esterase family. Indeed 188 
homologues of this enzyme are encoded by several Clostridium cluster XIVa strains from the human 189 
gut and by a range of Firmicutes (Supplementary Fig. 7i). 190 
Assaying RiAXE activity towards AcBGX oligosaccharides (generated with RiXyn10A) using NMR 191 
revealed efficient deacetylation of both C2 and C3, but with a preference for C2 decorations (Fig. 4b 192 
and Supplementary 7). Analysis of the deacetylation by MALDI-ToF MS left a single acetyl group on 193 
the AcBGX oligosaccharides (Fig. 4e). Inclusion of RiAgu115A in this reaction resulted in complete 194 
deacetylation (Fig. 4f) suggesting that the presence of MeGlcA decorations protects acetylations in 195 
the proximity of the MeGlcA unit. Analysis of the deacetylation rates also unveiled the concerted 196 
action with RiAgu115A and the preference to hydrolysates of RiXyn10A rather than intact xylan 197 
(Supplementary Fig. 7c,d). RiAXE specifically recognizes acetylations on xylosyl units based on lack of 198 
activity on acetylated chitin and very low activity on acetylated mannan and cellulose monoacetate 199 
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(Supplementary Fig. 7h). Taken together, the results showed that RiAXE is an efficient xylan specific 200 
representative of a new acetyl esterase family.  201 
In summary of the biochemical characterization presented above, we propose a model for the 202 
uptake and degradation of diet-derived acetylated arabinoxylan and glucuronoxylan by R. intestinalis 203 
L1-82 (Fig. 5a). 204 
 205 
R. intestinalis competes with Bacteriodes for xylans 206 
The growth potential of R. intestinalis was compared with the efficient xylan degrader Bacteroides 207 
ovatus22, by observing growth of individual cultures and in co-culture. Both strains displayed similar 208 
growth on xylan as carbon source (Fig. 5b-d and Supplementary Fig. 8a,b). In competition, both 209 
strains appeared to grow equally well on xylans (Fig. 5e-g), whereas R. intestinalis dominated the co-210 
culture on X4 after 7 hours of growth (Fig. 5h). The results indicate that R. intestinalis is an efficient 211 
primary degrader of xylan that is able to compete with B. ovatus and even outcompete this 212 
bacterium on preferred smaller xylo-oligosaccharides.  213 
 214 
Discussion  215 
The human gut is dominated by bacteria from two phyla: the Gram-positive Firmicutes and the 216 
Gram-negative Bacteriodetes. Firmicutes are generally regarded as metabolic specialists, while 217 
Bacteroidetes (mainly from the Bacteroides genus) are considered generalists based on narrow 218 
versus broad glycan utilization capabilities, respectively6. The size and diversity of encoded CAZymes 219 
frequently reflects these metabolic labels. Although this generalization applies to R. intestinalis, 220 
based on the relatively limited glycan growth profiles5,  this species possesses distinctively larger 221 
CAZymes than most known clostridial Firmicutes of the HGM17. R. intestinalis has been proposed as a 222 
key xylan degrader in the human gut along with specific species of Bacteroides18,19. Growth and 223 
enumeration of R. intestinalis on dietary xylans including wheat bran is reported both in vitro and in 224 
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vivo20,32. Insight is lacking, however, on the preferences and the molecular machinery evolved by R. 225 
intestinalis to target xylan as compared to species of Bacteriodes. In this study, we present a model 226 
that explains the molecular basis for the utilization of xylan by R. intestinalis L1-82 as a 227 
representative for prevalent butyrate producing clostridia (Fig. 5a). Our data establish that R. 228 
intestinalis is truly a primary degrader that is equipped with a highly efficient machinery for 229 
utilization of complex dietary xylans, including insoluble arabinoxylan from cereals. Identified key 230 
components of the R. intestinalis xylan utilization strategy include a multi-modular extracellular 231 
xylanase and an ABC transporter, which confer the capture, breakdown and internalization of 232 
decorated xylan oligosaccharides. In the cytoplasm, internalized xylo-oligosaccharides are 233 
depolymerized without loss to competing species. We demonstrate the ability of R. intestinalis to 234 
grow on acetylated xylan, which reflects an adaptation to this abundant decoration in dietary xylans 235 
(Fig. 1b). Acetylated xylo-oligosaccharides are metabolized after internalization due to an 236 
intracellular previously unknown esterase family capable of removing C2, C3 and double acetylations 237 
(Fig. 4b and Supplementary Fig. 7).  238 
The extracellular multi-modular xylanase RiXyn10A, the ABC transporter and enzymes conferring 239 
cytoplasmic breakdown of xylan oligosaccharides were assigned as the core xylan utilization 240 
apparatus of R. intestinalis (Fig. 2a,b). This assignment was based on i) conservation of this 241 
apparatus within the Roseburia species (Supplementary Fig. 2a), ii) highest transcriptional 242 
upregulation of the encoding genes on xylan (Fig. 2a), and iii) biochemical data from the present 243 
study. The two additional xylan-upregulated loci in R. intestinalis L1-82 (Supplementary Fig. 1) are 244 
lacking in R. intestinalis XB6B4 and R. intestinalis M50/1, both being able to grow on xylan20. The 245 
activity and expression of the xylanase RiXyn10B, encoded by one of these auxiliary loci 246 
(Supplementary Fig. 3d), supports the participation of more than one locus in xylan breakdown in R. 247 
intestinalis L1-82. Multiplicity of xylan utilization loci has been suggested to support targeting a 248 
larger structural diversity of naturally occurring xylans by Bacteroides22, which may also apply for R. 249 
intestinalis.  250 
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Our data support the role of the R. intestinalis core xylanase RiXyn10A in mediating the capture and 251 
breakdown of arabino- and glucuronoxylan (Fig. 1 and Fig. 3). This enzyme possesses four CBMs 252 
from two known and one novel xylan-binding families, representing the most complex modular 253 
organisation of HGM xylanases (Fig. 3a and Supplementary Fig. 2b). This organization is conserved 254 
within the currently sequenced R. intestinalis species, while other Clostridium XIVa taxa possess 255 
simpler enzymes lacking one or more of the RiXyn10A CBMs. The N-terminal CBMx of RiXyn10A 256 
displays approximately 7-fold lower affinity for X6 than the average affinity measured for the 257 
enzyme variant lacking this module (Fig. 3e). These data merit assigning this module into a novel 258 
low-affinity xylan-specific CBM family. Nonetheless, CBMx is highly selective to arabinoxylan and 259 
clearly contributes to the overall affinity of the enzyme (Fig. 3e). Low-affinity CBMs may potentiate 260 
multivalent cooperative substrate binding, with minimal reduction of turn-over due to the energetic 261 
penalty of bond-breaking during substrate displacement from the active site (i.e maintenance of a 262 
relatively high kcat/koff ratio33). The extended binding mediated by the CBMs of RiXyn10A seems to 263 
confer an advantage in the capture and prolonged contact of the enzyme with xylan. Deletion of the 264 
binding modules (RiXyn10A-cata) caused a substantial decrease in the apparent affinity towards 265 
WAX and BGX as judged by the loss of curvature and deviation from Michaelis-Menten kinetics (Fig. 266 
3d and Supplementary Fig. 3b). These findings are consistent with the importance of CBMs in 267 
catalysis under substrate limitations. By contrast, similar turnover rates, were obtained by the 268 
catalytic module and the full-length RiXyn10A at high (9 mg mL-1) substrate concentrations 269 
(Supplementary Fig. 3b). Multiplicity and variability of CBMs seem to be a signature of extracellular 270 
enzymes from butyrate producing Firmicutes34,35. By contrast, Bacteriodes members possess simpler 271 
outer-membrane anchored GH10 xylanases with an inserted tandem CBM4 repeat within the 272 
catalytic module23. Xylan capture by Bacteriodes, however, is additionally orchestrated by moderate 273 
affinity (KD≈60 µM) xylan binding proteins that protrude away from the cell surface to facilitate 274 
binding22. 275 
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R. intestinalis was able to compete with B. ovatus for xylans during the log-phase (Fig. 5e-g). Notably, 276 
R. intestinalis seemed to outcompete B. ovatus after propagation of the co-culture (in the late log 277 
phase) in fresh medium for two additional passages, which underscores the competitiveness of the 278 
xylan utilisation machinery of this Firmicute (Supplementary Fig. 8c). R. intestinalis has been 279 
reported to be associated to insoluble xylans, including wheat bran, while species of Bacteriodes 280 
were enriched in the solubilized xylan fractions18,36. The extended binding mediated by RiXyn10A 281 
may play an important role in the association to insoluble substrates. Indeed, the expression of this 282 
enzyme appeared similarly high in the mono- and mixed xylan cultures with B. ovatus 283 
(Supplementary Fig. 8e). These observations are different from the reported down-regulation of 284 
hydrolases by Eubacterium rectale, which is close taxonomic relative to Roseburia, during co-growth 285 
with Bacteriodes thetaiotamicron on a fiber rich diet in previously germ-free mice37. 286 
The gene encoding the binding protein (RiXBP) of the ABC transporter that confers xylo-287 
oligosaccharide uptake in R. intestinalis was the most upregulated in the xylan transcriptomes, 288 
attesting the crucial role of oligosaccharide capture and transport in the densely populated gut 289 
ecological niche. The narrow preference of this protein for decorated backbone of 4−5 xylosyl units 290 
aligned with the products of RiXyn10A (Fig. 3b and Fig. 4c). The affinity and size preference of RiXBP 291 
were found to be very different from the corresponding protein from Bifidobacterium29, which 292 
prefers shorter xylo-oligosaccharides with a different side chain decoration pattern. Importantly, 293 
striking differences in binding affinities and preference are observed when RiXBP is compared to the 294 
SusD-like xylan-binding counterpart from Bacteriodes. Indeed, both SusD-like proteins from B. 295 
ovatus, which mediate capture and internalization of xylan-oligosaccharides ≥ X6 by SusC TonB-296 
dependent permeases, displayed no measurable binding to X4 and X522, the preferred ligands of 297 
RiXBP. These differential transport protein preferences are likely to be instrumental in establishing 298 
competitive uptake profiles to select oligosaccharides of specific sizes and decorations for each 299 
taxon. This is supported by the dominance of R. intestinalis when the co-culture with B. ovatus was 300 
grown on X4 (Fig. 5h).  301 
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Our study highlights the molecular apparatus that R. intestinalis, as a model Clostridium group XIVa 302 
Firmicute, has evolved to compete for abundant dietary glycans with other dominant commensal 303 
bacteria. Strikingly complex enzymes with multiple ancillary modules mediate multivalent substrate 304 
capture and breakdown. Highly over-expressed ABC transporters mediate efficient capture and 305 
uptake of xylan oligosaccharides with a different preference than the corresponding transport 306 
systems of currently known competing taxa. Based on these findings we propose that the 307 
differentiation of glycan capture and uptake preferences represents an adaptation strategy to 308 
facilitate co-growth and minimize competition for break down oligomers from major dietary fibers 309 
by different human gut taxa.  310 
This study gives insight into the mechanism that enables co-growth of prevalent human gut 311 
commensals on the same dietary fiber and sets the stage for the design of better therapeutic 312 
strategies aiming at restoring or boosting specific taxonomic groups in a safe and more controlled 313 
manner than currently possible. 314 
 315 
Methods 316 
Chemicals 317 
All chemicals were of analytical grade. Birchwood glucuronoxylan (BGX), beechwood glucuronoxylan 318 
BeGX), corncob xylo-oligosaccharides (CCXOS) and xylose were from Carl Roth (Karlsruhe, Germany). 319 
Cornbran xylan (CBX) was a kind gift from Dr. Madhav, Yadav, United States Department of 320 
Agriculture, Agricultural Research Service. Soluble wheat arabinoxylan (low viscosity 10 centiStokes 321 
(cSt)) (WAX), insoluble wheat arabinoxylan (high viscosity 48 cSt) (InWAX), xylobiose through to 322 
xylohexaose (X2−X6), arabinoxylotriose (AX3), arabinoxylotetraose (AX4)   and mannohexaose 323 
(Man6) were from Megazyme (Wicklow, Ireland). D-Glucuronic acid was from Sigma Aldrich (St. 324 
Louis, MO, USA). L-arabinose was from VWR International Ltd (Lutterworth, Leicestershire, UK). Xylo-325 
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oligosaccharides Longlive 95P (XOS) were from Shandon Longlive Bio-technology (Shandong, China). 326 
Acetylated birchwood glucuronoxylan (AcBGX), acetylated aspen glucuronoxylan (AcAGX), acetylated 327 
spruce galactoglucomannan (AcSGGM) were prepared with steam explosion as previously 328 
described38. Cellulose acetate was a kind gift from Alexander Deutschle, University of Hamburg, 329 
Germany. Acetylated chitin-oligosaccharides were prepared as previously described39.  330 
 331 
Growth experiments and RNA-seq transcriptional analysis  332 
R. intestinalis DSM 14610 was grown in a Whitley DG250 Anaerobic Workstation (Don Whitley, UK) 333 
in YCFA medium14 supplemented with autoclaved-sterilized 0.5% (w/v) carbohydrates. Cultures 334 
(5mL) were grown in triplicates and OD600 nm and pH (for insoluble substrates) were measured to 335 
assess bacterial growth until the stationary phase was reached. Growth rates were calculated from 336 
the exponential growth phase. 337 
For the RNA-seq analysis, total RNA was extracted at mid- to late-log phase (OD600 nm = 0.5−0.7) from 338 
biological triplicate cultures (10 mL) grown in YCFA supplemented with 0.5% (w/v) glucose, xylose, 339 
WAX or BGX. Cells were harvested (4000 g, 5 min, room temperature) and the pellets were frozen at 340 
-80°C until RNA extraction. The RNA was extracted using the RNeasy Mini Kit (Qiagen) according to 341 
the manufacturer’s protocol after enzymatic lysis followed by mechanical disruption of the cells. A 342 
DNase treatment was included to ensure removal of DNA. The purity and quantity of the extracted 343 
RNA were assessed by an Agilent 2100 Bioanalyzer (Agilent Technologies, UK). Removal of ribosomal 344 
RNA and library construction for RNAseq were performed using the ScriptSeqTM Complete Kit 345 
(Epicentre). High-throughput sequencing was performed in a single lane in paired end reads on an 346 
Illumina Hiseq 4000 platform at BGI (Copenhagen, Denmark). In total, 400 million paired-end reads 347 
were obtained and the read quality was assessed by FastQC v0.11.5 348 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The R1 reads were chosen for 349 
downstream analysis.  Adaptor trimming and de-multiplexing was performed using custom python 350 
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scripts (based on the Biopython SeqIO module40) and the FASTX-Toolkit v0.0.13.2 351 
(http://hannonlab.cshl.edu/fastx_toolkit/). Reads were further trimmed with fastx_trimmer and 352 
subsequently, filtered with fastq_quality_filter with minimum quality score 30 (-q 30) where 95% of 353 
base-pairs meet the minimum quality score (-p 95). The resulting reads were kept if longer than 20 354 
bps (-m 20). The R. intestinalis L1-82 reference genome and genome annotations are based on 355 
assembly GCA_000156535.1_ASM15653v1, obtained from NCBI 356 
(ftp://ftp.ncbi.nlm.nih.gov/genomes/genbank/bacteria/Roseburia_intestinalis/). Reads were 357 
mapped to the reference genome using Tophat241,42, and gene counts were determined with 358 
HTseq43. Differential gene expression was performed using DeSeq2 in R44. 359 
 360 
Xylanase activity measurements on whole cells  361 
Cell-associated xylanase activity was determined by growing R. intestinalis cells in 800 µL YCFA 362 
containing 0.5% (w/v) xylo-oligosaccharides, WAX, BGX or glucose for 15 hours. Cells were harvested 363 
(4000 g, 5 min, room temperature), resuspended in phosphate-buffered saline (PBS) to OD600 nm = 0.3 364 
and xylanase activity was assayed using the DNS assay as described below. To determine the effect 365 
of high ionic strength on the localization of xylanase activity, R. intestinalis cells were grown in 6 mL 366 
YCFA containing 0.5% (w/v) BGX for 15 hours. Subsequently, the culture was divided into two 3 mL 367 
aliquots and harvested as described above. Cell pellets were resuspended in 300 µL PBS with or 368 
without 1.5 M NaCl. The suspensions were spun down and both pellets and supernatants (wash 369 
fractions) were collected. Cell pellets were washed with excess PBS and resuspended in 300 µL PBS. 370 
The xylanase activity of cells and wash fractions was assayed using the DNS assay. 371 
 372 
Expression and purification of R. intestinalis proteins mediating xylan utilization 373 
16 
 
Open reading frames of the proteins without signal peptide, as predicted by SignalP v.3.0 374 
(http://www.cbs.dtu.dk/services/SignalP-3.0), were amplified from R. intestinalis DSM 14610 375 
genomic DNA using specific primers (Supplementary Fig. 9). Amplicons were cloned into the EcoRI 376 
and NcoI restriction sites of a pETM-11 (kind gift from Dr. Gunter Stier, EMBL, Center for 377 
Biochemistry, Heidelberg, Germany45 or the XhoI and NcoI restriction site of a pET28a(+) (Novagen, 378 
Darmstadt, Germany) using In-Fusion cloning (Takara) to express proteins as fusions with either 379 
cleavable N-terminal His6 tags or a C-terminal ones, respectively. Standard protocols were used for 380 
recombinant protein expression and purification using His-affinity and size exclusion 381 
chromatography.  382 
Enzymatic activity assays 383 
Enzymatic assays were carried out in a 50 mM HEPES 0.005% (v/v) Triton X-100, pH 7.0 standard 384 
assay buffer unless otherwise stated. Hydrolysis kinetics of full-length or truncated xylanases 385 
(10−200 nM) were assayed towards 1−9 mg mL-1 of BGX, WAX or InWAX (37°C, 900 µL, 12 min). 386 
Initial hydrolysis rates were determined by removing 200 µL aliquots every third minutes and 387 
quenching the reaction in 300 µL 3,5-dinitrosalicylic acid (DNS) reagent46. Next samples were 388 
incubated for 15 min at 90°C followed by A540 nm measurement in 96 microtitre plates. Xylose was 389 
used as a standard (0−2.5 mM). Xylanase activity was assayed for R. intestinalis cells washed with 390 
PBS ± 1.5 M NaCl, and wash-fractions, as above with the following modification: 180 µL of 1% (w/v) 391 
BGX was incubated with 20 µL cell suspension or wash-fraction for 4 hours.      392 
Hydrolysis kinetics of α-glucuronidase were analyzed on 1−9 mg mL-1 BeGX or a hydrolysate thereof 393 
(prepared by incubation with 4 mM RiXyn10A xylanase for 15 hours at 37°C followed by heat 394 
inactivation). The initial rates of (O-methyl)-D-glucuronic acid release were measured using a 395 
coupled enzymatic assay (Megazyme). Reactions (770 µL) were incubated for 2 min at 37°C with 396 
10−180 nM enzyme with intermittent removal of 175 µL aliquots every 15 s into 125 µL 1 M Tris pH 397 
10 to quench the reaction. This was followed by mixing 270 µL of the stopped reaction with 45 µl of 398 
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the NAD+ and uronate dehydrogenase reagents. Conversion of NAD+ to NADH was measured at A340 399 
nm. Glucuronic acid was used as standard (0−500 µM).  400 
Hydrolysis kinetics of RiXyl8 and RiXyl3A were determined towards xylobiose (X2) through to 401 
xylohexaose (X6)  (0.5-12 mM) in McIlvaine buffer pH 6.8 (10 mM citric acid and 20 mM sodium 402 
phosphate) as described in47,48. Reactions (350 µL) were incubated for 12 min at 37°C with 36−78 nM 403 
RiXyl3A or 2.4 nM RiXyn8. Aliquots of 50 µL were removed every 2 minutes and stopped in 250 µL p-404 
bromoaniline (2% w/v) in glacial acetic acid with thiourea (4% w/v). The stopped reactions were 405 
incubated in darkness for 10 min at 70°C, followed by incubation at 37°C for 1 hour before 406 
measuring A520 nm. The concentration of released pentoses was determined using a xylose standard 407 
(0−5 mM)49.  408 
α-L-Arabinofuranosidase activity for RiAbf43A was assayed in McIlvaine buffer pH 6.8 (10 mM citric 409 
acid and 20 mM sodium phosphate) using a coupled enzymatic L-arabinose/D-galactose assay 410 
(Megazyme) towards WAX (1−24 mg mL-1). Reactions (75 µL) were incubated for 12 min at 37°C with 411 
0.4−1.7 µM enzyme. Aliquots of 15 µL were removed every 2 min, and the enzyme was inactivated 412 
(10 min, 90°C) and thereafter 10 µL of this solution were mixed with 10 µL of the provided NAD+, 20 413 
µL of provided assay buffer and 2 µL galactose mutaotase/β-galactose dehydrogenase mix. The 414 
formation of NADH was measured as above. Arabinose was used as standard (0−5 mM).  415 
The acetyl esterase specific activity of RiAXE was determined in 250 µL reactions containing para-416 
nitrophenyl-acetate (4 mM) and 0.14 µM enzyme.  A405 nm was measured every 60 s for 10 minutes 417 
at 37°C in a microtiter plate reader and pNP (0−1 mM) was used as standard. The specific activity 418 
was determined in units (U/mg), where a U is defined as the amount of enzyme that produces 1 419 
µmol of pNP min-1.  420 
Kinetic parameters were calculated by fitting the Michaelis-Menten equation to the initial rate data 421 
using Graph Pad Prism 7. The catalytic efficiency kcat/Km, determined from the slope of the 422 
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normalized initial rate (V0/[E]) in the Michaelis-Menten plot, is reported when saturation was not 423 
attained. All experiments were performed in triplicates. 424 
Action patterns of individual and mixtures of xylanolytic enzymes 425 
Hydrolysis of xylan and xylo-oligosachharides was performed at 37°C for 15 hours in the standard 426 
assay buffer used above. Oligosaccharide hydrolysates, used to assay the sequential action of the 427 
debranching xylanolytic enzymes, were generated using RiXyn10A, which was separated by 428 
ultrafiltration (3 kDa cutoff) before the addition of debranching enzymes. The hydrolysis profiles 429 
were analyzed as detailed below. To verify the mode of reducing-end attack of RiXyl8, 30 mg XOS in 430 
standard assay buffer were reduced by NaBH4 (1M in 100 µM NaOH).  A total of 200 µL of the NaBH4 431 
was added dropwise to 800 µL of the xylo-oligossaccharides solution, which was kept on ice. As 432 
control 100 µM NaOH was added to an 800 µL xylo-oligossaccharides solution. The mixture was 433 
incubated 1 hour at room temperature, then quenched by 400 µL 1 M acetic acid and diluted 10x in 434 
assay buffer.  435 
Matrix-assisted laser desorption-ionization (MALDI) 436 
Oligosaccharides were analyzed with an Ultraflex MALDI ToF/ToF instrument (Bruker Daltonics, 437 
Bremen, Germany). The samples were applied with 2,5-dihydroxybenzoic acid (DHB) as matrix to a 438 
MTP 384 ground steel target plate (Bruker Daltonics). All spectra were obtained in positive reflection 439 
mode and processed using Bruker flexAnalysis 3.3.  440 
Thin layer chromatography (TLC) and High performance anion-exchange chromatography with 441 
pulsed amperometric detection (HPAEC-PAD) 442 
Aliquots of 1 µL of enzymatic reactions were spotted on a silica gel 60 F254 plate (Merck, Germany). 443 
The chromatography was performed in a butanol:acetic acid:water (2:1:1 v/v) mobile phase. The 444 
plates were dried at 50°C and carbohydrate hydrolysis products were visualized by spraying with a 5-445 
methylresorcinol:ethanol:sulfuric acid (2:80:10 % v/v) developer and tarred briefly at 350°C until 446 
19 
 
bands appeared. Release of xylo-oligossaccharides and monosaccharides was analyzed by HPAEC-447 
PAD on an ICS-3000 (Dionex, CA, USA) using a 3x250mm CarboPac PA1 column, a 3x50 mm guard 448 
column and 10 µL injections. Xylo-oligosaccharide and standards were eluted with mobile phase of 449 
constant 0.1 mM NaOH (flowrate 0.35 mL min-1) and a two-step linear gradient of sodium acetate; 450 
0−25 min of 0−75 mM and 25−30 min of 75−400 mM. Monosaccharides and standards (0.1 mg mL-1) 451 
of galactose, arabinose, glucose and xylose were eluted with 1 mM KOH for 35 min at 0.25 mL min-1. 452 
 453 
NMR spectroscopy 454 
For the time-resolved NMR recordings: 4 mg AcBGX or AcSGGM were dissolved in 500 µL 50 mM 455 
phosphate buffer pH 7.0 (99.9% D2O). 2.5 µL of RiAXE to a final concentration of 64 nM was added. 456 
The recorded spectrum is a pseudo-2D type experiment recording a 1D proton NMR spectrum every 457 
5 min with in total 220 time points. The 1D proton spectrum was recorded with 24 scans using a 30° 458 
flip angle, and relaxation delay of 1 s (total recording time of 73 s). For enzyme treatment, 2.5 µL of 459 
RiXyn10A and RiAgu115A were added to the AcBGX sample to 167 nM and 13 nM, respectively, and 460 
the sample incubated at 37°C for 24 hours prior to RiAXE addition. All homo and heteronuclear NMR 461 
experiments were recorded on a BRUKER AVIIIHD 800 MHz (Bruker BioSpin AG, Fälladen, 462 
Switzerland) equipped with 5mm with cryogenic CP-TCI and all acquisitions were done at 37°C. For 463 
chemical shift assignment of AcBGX, the following spectra were recorded: 1D proton, 2D double 464 
quantum filtered correlation spectroscopy (DQF-COSY), 2D total correlation spectroscopy (TOCSY), 465 
2D 13C heteronuclear single quantum coherence (HSQC), 2D 13C Heteronuclear 2 Bond Correlation 466 
(H2BC), 2D 13C HSQC-[1H,1H]TOCSY and 2D heteronuclear multiple bond correlation (HMBC). The 467 
acetate signal to 1.903 ppm (pH 7.0 at 37 °C, in relation to 4,4-dimethyl-4-silapentane-1-sulfonic 468 
acid, DSS50) was used as chemical shift reference for protons, while 13C chemical shifts were 469 
referenced indirectly to acetate, based on the absolute frequency ratios51. The spectra were 470 
recorded, processed and analyzed using TopSpin 3.5 software (Bruker BioSpin). 471 
 472 
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Surface plasmon resonance (SPR) 473 
Xylo-oligosaccharide binding to RiXyn10A, RiXyn10AΔCBMx and RiXyn10A-CBMx was analyzed using 474 
surface plasmon resonance (SPR) on a BIAcore T100 (GE Healthcare). Immobilization of the proteins 475 
on a CM5 chips was performed using a random amine coupling kit (GE Healthcare) according to the 476 
manufacture’s protocol with 50-150 µg mL-1 protein in 10 mM sodium acetate pH 3.6-4.2, to a 477 
density of 1362, 10531 and 4041 response units (RU) for RiXyn10A∆CBMx, RiXyn10A and RiXyn10A-478 
CBMx, respectively. The analysis comprised 90 s of association, 240 s of dissociation at 30 µL min-1. 479 
Sensograms were recorded at 25°C in 20 mM phosphate/citrate buffer, pH 6.5, 150 mM NaCl, 480 
0.005% (v/v) P20 (GE Healthcare). All solutions were filtered prior to analysis (0.22 μm). Experiments 481 
were performed in duplicates with seven concentrations in the range 156 µM−10 mM for X3, 75 482 
µM−4 mM for X4, X6, Man6 and 62.5 µM−4 mM X5. Data analysis was carried out using the Biacore 483 
T100 evaluation software and dissociation constants (KD) were determined by fitting a one-binding 484 
site model to the steady state sensograms. No binding was measured for Man6. 485 
Isothermal titration calorimetry (ITC) 486 
Titrations were performed using a Microcal ITC200 calorimeter (GE healthcare) at 25°C with RiXBP 487 
(0.1 mM) or RiXyn10A∆CBMx (0.25 mM) in the sample cell and xylo-oligosaccharides (2.2−5 mM) in 488 
10 mM sodium phosphate pH 6.5 in the syringe. An initial injection of 0.5 µL, was followed by 19 x 2 489 
µL injections separated by 120 s. The data were corrected for the heat of dilution, determined from 490 
buffer titration and a nonlinear single binding model was fitted to the normalized integrated binding 491 
isotherms using the MicroCal Origin software v7.0 to determine the thermodynamic binding 492 
parameters. 493 
Affinity electrophoresis  494 
Binding of CBMx to WAX (0−0.1% w/v) or BGX (0−1.0% w/v) was assessed by affinity 495 
electrophoresis52 in 10% native polyacrylamide gels (70 V, 3 hours, 4°C) using purified recombinant 496 
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RiXyn10A-CBMx (3.0 µg) and ß-lactoglobulin (1.5 µg) as a negative control. The relative mobility (r) 497 
was calculated as the migration of RiXyn10A-CBMx relative to migration of the dye front. A linear 498 
regression of the 1/r versus xylan concentration allowed the determination of KD as the intercept of 499 
this X-axis. 500 
 501 
Western blot and immunofluorescence microscopy 502 
Custom antibodies against the recombinant for the two xylanases RiXyn10A, RiXyn10B and the 503 
transport protein RiXBP were raised in rats and rabbit, respectively (Eurogentec, Seraing, Belgium). 504 
The specificity of the antibodies was tested by western blots using a standard protocol. The 505 
membranes were blocked for 1 hour in 1% (w/v) BSA in TBST-buffer (Tris-buffered saline, 0.1% (v/v 506 
Tween 20) and incubated for 2 hours with the antisera (500x dilution in TBST-buffer). Subsequently, 507 
the membranes were washed three times in TBST-buffer and incubated for 2 hours with 6000x 508 
diluted secondary polyclonal goat anti-rabbit IgG-AP antibodies coupled to alkaline phosphatase (AP) 509 
(Dako, Glostrup, Denmark) and rabbit anti-rat IgG-AP (Sigma). After three washes, the proteins were 510 
visualized by exposure to Sigma-Fast BCIP/NBT reagent (Sigma).  511 
R. intestinalis cells were grown in 6 mL YCFA containing 0.5% (w/v) WAX to OD600 nm≈0.8, harvested 512 
(4000 g, 5 min, room temperature) and washed twice in PBS. The cells were resuspended in 3 mL 4% 513 
(w/v) paraformaldehyde in PBS and fixed by incubation on ice for 15 min. Thereafter the cells were 514 
washed twice in PBS and resuspended in 2 mL PBS. 50 µL of cell suspension were added to glass 515 
slides coated with poly-L-lysine, cells blocked for 1 hour in blocking buffer (1% (w/v) milk powder in 516 
PBS) and washed twice in PBS. For labelling, the cells were incubated with 50 µL anti-sera diluted 50x 517 
in blocking buffer for 2 hours, washed twice in PBS and incubated for 1 hour with 50 µL goat anti-rat 518 
IgG Alexa-Flour 555 or goat anti-rabbit IgG Alexa-Flour 488 (Thermo Scientific, Massachusetts, USA). 519 
Secondary antibodies were diluted 500x PBS. Finally, cells were washed two times in PBS, one drop 520 
of ProLong Gold antifade (Thermo Scientific, Massachusetts, USA) was applied and the cells secured 521 
22 
 
with a cover slide. Fluorescence was visualized using Zeiss Axioplan 2 microscope equipped with a 522 
CoolSNAP cf color camera and a Zeiss Plan-Neofluar 100X/1.3NA, oil immersion objective.  523 
 524 
Co-culture competition assay 525 
Bacteriodes ovatus DSM 1896 and R. intestinalis DSM 14610 were grown anaerobically in 20 mL 526 
YCFA supplemented with 0.5% (w/v) glucose to late-log phase and an approximately equal number 527 
of cells (estimated by OD600 nm) were inoculated into CFA medium (YCFA lacking the yeast extract to 528 
minimize B. ovatus growth on yeast extract53) containing 0.5% (w/v) WAX, BGX, InWAX or X4. The 529 
co-cultures were grown in triplicates and samples (2 mL) were taken during growth. In the 530 
propagation experiment, the co-culture was passaged into fresh media after 9 hours of growth (start 531 
OD600 nm= 0.01), then grown for 12 hours and passaged again into fresh media and grown for 12 532 
hours. Genomic DNA was extracted from samples using DNAClean® Microbial DNA isolation kit 533 
(Qiagen). Relative bacterial abundance was estimated by qPCR. The extracted DNA was diluted to 534 
0.5 ng µL-1 and amplified in technical triplicates using strain specific primers (Supplementary Fig. 9) 535 
The amplification mix contained 2 μl DNA, 5.5 μl LightCycler 480 SYBR Green I Master mix (Roche), 536 
0.22 μL of each primer (10 pmol/µL) and 3 μL sterile water. Amplification conditions were 1 cycle of 537 
95 °C for 5 min, 45 cycles of 95 °C for 10 s, 60 °C for 15 s and 72°C for 45 s using a LightCycler 480 II 538 
(Roche).  Relative bacterial concentrations in each sample were estimated by comparing the gene 539 
copy numbers calculated using standard curves prepared with the respective reference DNA. 540 
Western blot was performed as described above but with cell cultures instead of purified proteins.  541 
 542 
Data availability 543 
The protein characterized in this study are available from NCBI with the following accession 544 
numbers: EEV01588.1 (ROSINTL182_06494), EEU99940.1 (ROSINTL182_08193), EEU99941.1 545 
(ROSINTL182_08194), EEU99942.1 (ROSINTL182_08195), EEU99943.1 (ROSINTL182_08196), 546 
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EEU99943.1 (ROSINTL182_08196), EEU99894.1 (ROSINTL182_08199) and EEU99897.1 547 
(ROSINTL182_08202). The authors declare that the data supporting the findings of this study are 548 
available within the paper and the supplementary information or from the corresponding author on 549 
request. 550 
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Figure legends 686 
Figure 1 Growth of R. intestinalis and induction of extracellular activity. (a) Schematic representation of cereal 687 
arabinoxylan and glucuronoxylan present in dicots cell wall, e.g. in fruits and vegetables. (b) Growth level for 18 hours on 688 
xylans, oligosaccharides thereof and monosaccharide components, with glucose as a control. Green: OD600 nm increase >1.0 689 
for soluble substrates and pH drop > 0.3 for insoluble xylans; yellow: 0.3 < ∆OD600 nm < 0.5; red: ∆OD600  nm< 0.1. Asterisks 690 
indicate insoluble xylans (c) Growth curves on glucose, wheat arabinoxylan (WAX), birch glucuronoxylan (BGX) and a no 691 
carbon source control. (d) Growth on insoluble wheat arabinoxylan (InWAX) and oatspelt xylan (OSX). All growth 692 
measurements are means of triplicates with standard deviations. (e) Xylanase activity of R. intestinalis cells grown on 693 
glucose, xylo-oligosaccharides, BGX and WAX for 18 hours. (f) Cells grown on BGX were washed (PBS buffer ± 1.5 M NaCl) 694 
and xylanase activity was measured in wash and cell fractions to verify localization of the enzymes. Xylanase activity was 695 
measured using the DNS reducing sugar assay and data are triplicates with standard deviations. 696 
Figure 2 The core xylan utilization apparatus of R. intestinalis. (a) The RNA-Seq heatmap depicts Log2 fold changes of the 697 
top upregulated xylan utilization genes expressed by cells grown on xylose (X1), wheat arabinoxylan (WAX) and birch 698 
glucuronoxylan (BGX) relative to glucose (Glc). Formal locus tag numbers ROSINTL182_xxxxx are abbreviated with the last 699 
numbers after the hyphen. Signal peptides (SP) were predicted using SignalP v.3.0. (b) Gene expression depicted as mean 700 
of the normalized Deseq2 gene counts for the core xylan utilization genes shown in (a). (c) Extracellular localization of 701 
29 
 
RiXBP and RiXyn10A, the solute binding protein of the xylo-oligosaccharide specific ABC transporter and the xylanase, 702 
respectively, were visualized by fluorescence microscopy of R. intestinalis cells using primary antibodies targeting these 703 
two proteins. No auto fluorescence was observed for cells without primary antibody (data not shown). 704 
Figure 3 A novel low affinity xylan binding module mediates extended xylan binding to the xylanase RiXyn10A. (a) 705 
Domain organization of RiXyn10A and truncated variants. Carbohydrate binding module (CBM), novel CBM (CBMx), 706 
bacterial Ig-like domain group 2 (BIG2), Listeria-Bacteroides repeat domain (LBR). (b,c) Xylanase activity of RiXyn10A on 707 
WAX and BGX assayed by HPAEC-PAD and thin layer chromatography, respectively. Peaks in 3b eluting after X6 are likely to 708 
be decorated xylo-oligosaccharides. (d) Hydrolysis kinetic parameters of RiXyn10A, RiXyn10A∆CBMx and RiXyn10A-cata 709 
towards WAX and BGX. Kinetics of the RiXyn10A-cata are not modelled by the Michaelis-Menten expression and catalytic 710 
efficiencies are estimated from linear regression of initial rate data. Data are means of triplicates with standard deviations. 711 
(e) Binding parameters of RiXyn10A and variants towards oligosaccharides.  Dissociation constants (KD) determined by 712 
surface plasmon resonance (SPR) are means of a duplicate with the standard deviations. * KD (mg mL-1) from affinity 713 
electrophoresis (AE), and ** KD from isothermal titration calorimetry (ITC). (f) Binding of RiXyn10A-CBMx to the negative 714 
control (no polysaccharide), WAX or BGX xylans analyzed using AE. Lanes 1+2; RiXyn10A-CBMx (3.0 µg), Lane 3; ß-715 
lactoglobulin negative control (1.5 µg), M; marker. (g) Binding isotherms of RiXyn10-CBMx to xylo-oligosaccharides. Solid 716 
lines are fits of a one binding site model to the SPR sensograms.    717 
Figure 4 Intracellular xylo-oligosaccharide depolymerization. (a) α-glucuronidase and α-L-arabinofuranosidase activity on 718 
WAX and BGX for RiAgu115A and RiAbf43A, respectively, based on HPAEC-PAD analysis. (b) Time-resolved NMR for RiAXE 719 
enzymatic deacetylation of acetylated birch glucuronoxylan (AcBGX) treated with RiXyn10A and RiAgu115A. Deacetylation 720 
time course for the first 30 min and after 18 h (green 0 min, purple 30 min, orange 18 h). All verified signals with 2-O-721 
acetylation decreased faster in the initial phase of the reaction. The proton spectra of the acetylated region show nearly 722 
complete deacetylation of the sample after 18 h. The signal at 2.13 ppm is likely attributed to another acetylated sugar 723 
residue.  Acetyl groups are designated as: C2, 2-O-acetylated xylose; C3, 3-O-acetylated xylose, C23, 2,3-di-O-acetylated 724 
xylose; C3-MeGlcA; 4-O-methylglucuronic acid 2-O-substituted and 3-O-acetylated xylose; C23(2); signal for the 2-O-725 
acetylated of C23. The assignment of the acetylated sugar signals were based on homo and heteronuclear NMR correlation 726 
experiments (Supplementary Fig. 7) (c-f) Hydrolysis products from AcBGX by (c) RiXyn10A, (d) RiXyn10A and RiAgu115A, (e) 727 
RiXyn10A and RiAXE, (f) RiXyn10A, RiAgu115A and RiAXE. Enzyme action was analyzed by MALDI-ToF MS; Xylo-728 
oligosaccharides decorated with acetyl and methylglucuronic acid are in green, acetyl in blue, methylglucuronic acid in red, 729 
no sidechains in orange. Di-sodium adducts of a methylglucuronic acid decorated oligosaccharides (diamonds) are colored 730 
as their corresponding single sodium adducts. 731 
30 
 
Figure 5 Model for xylan utilization by R. intestinalis and competition assay with Bacteriodes ovatus. (a) RiXyn10A on the 732 
cell surface efficiently captures diet-derived acetylated arabinoxylan and acetylated glucuronoxylan by its CBMs and 733 
hydrolyzes it into linear and decorated xylo-oligosaccharides, which are subsequently captured by RiXBP for uptake into 734 
the cytoplasm. Internalized xylo-oligosaccharides are debranched and hydrolyzed into monosaccharides and acetate. 735 
Xylose and arabinose are converted to xylulose 5-phosphate before entering the pentose phosphate pathway, whereas 736 
methyl-glucuronic acid is converted to 2-oxo-3-deoxygalactonate 6-phosphate. These precursors enter glycolysis, which 737 
generates pyruvate, some of which is used to synthesize butyrate31 that is externalized. The asterisk next to RiAbf43A 738 
indicates that the enzyme is able to hydrolyze both α-1,2 and α-1,3 linked L-arabinose. Black solid arrows show steps 739 
established or confirmed in this study. Grey solid arrows indicate steps described in literature. Grey dashed arrows indicate 740 
that H2 and butyrate are externalized by unknown mechanisms. To make the model more general for the R. intestinalis 741 
species, the second less upregulated extracellular xylanase RiXynB, unique for the L1-82 strain, is not included in the 742 
model, although it is expressed at the cell surface. (b-d) Growth of monoculture and co-cultures of R. intestinalis and B. 743 
ovatus on WAX, InWAX and BGX. Data are means of a triplicate with standard deviations.  (e-h) Time course relative 744 
abundance during growth of co-cultures on xylans and xylotetraose (X4) determined by qPCR. All data are means of a 745 
biological triplicate. 746 
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Table 1:  Binding energetics of the transport protein RiXBP to xylo-oligosaccharides determined by ITC  
Ligand 
KD
 
(µM) 
N0 ∆H 
(kcal/mol) 
T∆S 
(kcal/mol) 
∆G 
(kcal/mol) 
 
       
X6 112.7 ± 7.5 1.19 ± 0.14 -9.01 ± 1.3 -3.6 -5.4 
 
X5 10.3 ± 1.5 0.86 ± 0.01 -13.54 ± 0.3 -6.7 -6.8 
 
X4 16.5 ± 2.6 0.68 ± 0.02 -12.8 ± 0.4 -6.3 -6.5 
 
X3 225.7 ± 14.5 0.58 ± 0.23 -21.1 ± 9.5 -16.1 -5.0 
 
X2 n.d.     
 
AX3 215.5 ± 95.2 0.26 ±  0.04 -44.3 ± 7.1 -39.4 -4.9 
 
AX4 6.8 ± 1.2 0.58 ± 0.01 -12.3 ± 0.2 -7.0 -5.3 
 
Data are means of a duplicate experiment with standard deviations. n.d. indicates that no binding was observed. 
AX3 is an arabino-xylotriose with a non-reducing end arabinosyl and AX4 is an arabino-xylotetraose with an 
arabinosyl decoration at the penultimate position from the non-reducing end (see Supplementary Fig. 5h,i).  
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Supplementary Table 2. Modular organization of GH10 xylanases from human gut Firmicutes and Bacteroidetes. 
Phylum Family Strain Accession number  Length (AA) CBMs 
Firmicutes Lachnospiraceae Roseburia intestinalis L1-82 ROSINTL182_06494 1356 X, 22, 9, 9  
   ROSINTL182_6338-9 601  
  Roseburia intestinalis XB6B4 CBL13458.1 1356 X, 22, 9, 9 
  Roseburia intestinalis M50/1 n.a. 1356 X, 22, 9, 9 
  Roseburia faecis M72 CRL32809.1 1380 X, 22, 9, 9 
  Eubacterium rectale T1-815 CRL34489.1 1028 X, 9, 9 
  Butyrivibrio fibrisolvens 16/4 CBK74925.1 1153 9 
   CBK75021.1 690 13, 2 
  Hungatella hathewayi CUO52114.1 421  
  Ruminococcus gnavus WP_064787180.1 394  
      
 Ruminococcaceae Ruminococcus champanellensis 
18P13 
CBL16579.1 633 22 
   CBL17682.1 1268 22, 22, 6 
      
  Ruminococcus callidus ATCC 27760 ERJ94429.1 1158 22, 22, 9 
   ERJ87773.1 630 22 
   ERJ97032.1 382 22 
      
Bacteroidetes Bacteroidaceae Bacteroides ovatus EDO13863.1 372  
   EDO10007.11 376  
   EDO14247.1 573  
   EDO10010.11 740 4, 4 
   EDO14052.1 584  
   EDO10798.1 750  
  Bacteroides intestinalis DSM 17393 EDV05054.1 782 4, 4 
   EDV05072.12 746 4, 4 
   EDV03684.1 738  
   EDV05059.1 910  
   EDV07678.1 725  
   EDV07007.12 899  
  Bacteroides xylanisolvens XB1A CBK67953.13 754 4, 4 
   CBH32823.1 378  
AA: amino acids, n.a.: GH10 is present, but not assigned in the genome,  
1. Rogowski, A. et al. Glycan complexity dictates microbial resource allocation in the large intestine. Nat. Commun. 6, 7481 (2015). 
2. Zhang, M. et al. Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes. 
Proc. Natl. Acad. Sci. U. S. A. 111, E3708-E3717 (2014) 
3. Despres, J. et al. Xylan degradation by the human gut Bacteroides xylanisolvens XB1AT involves two distinct gene clusters that are linked at the 
transcriptional level. BMC Genomics 17, 326 (2016). 
 
 
Supplementary Table 3. Thermodynamic parameters and dissociation constant for RiXyn10A-CBMx determined by ITC. 
Ligand KD  (µM) N0 ∆H (kcal/mol) T∆S(kcal/mol) ∆G (kcal/mol) 
      
X6 413 ± 125 0.74 ± 0.04 -19.9 ± 1.2 -15.3 -4.6 
Data are from one experiment and binding parameters are reported with the error of the fit to the binding isotherm.  
 
 
 
Supplementary Table 4. Homologs of CBMx identified in genomes of taxonomically related taxa to R. intestinalis. 
Strain Accession number Query cover E-value Identity 
Roseburia intestinalis XB6B4 CBL13458.1 100% 4e-85 100% 
Eubacterium rectale_T1815 CRL34489.1 89% 5e-36 55% 
Butyrivibrio sp. LC3010 WP_026509692.1 92% 1e-07 36% 
Roseburia faecis M72 CRL32809.1 93% 9e-12 36% 
Bacterium enrichment culture clone MC3F AFU34339.1 86% 3e-07 30% 
Lachnoclostridium phytofermentans ISDg ABX41884.1 84% 5e-07 26% 
Clostridium sp. KNHs205 WP_033165005.1 88% 1e-06 28% 
Butyrivibrio sp. INlla14 SCX91715.1 63% 2e-06 32% 
Lachnospiraceae bacterium YSD2013 SCX14282.1 73% 1e-05 34% 
Butyrivibrio sp. ob235 SEK63083.1 76% 2e-04 30% 
Butyrivibrio sp. VCD2006 WP_026526370.1 72% 3e-04 27% 
     
 
Supplementary Table 5. Kinetic parameters of RiAgu115A.  
Substrate KM 
(mg mL-1) 
kcat 
(s-1) 
kcat/KM 
(mL mg-1 s-1) 
 
BeGX 
 
n.d. 
 
n.d. 
 
2 
BeGX + RiXyn10A 12 ± 3 395 ± 34 33 
n.d.: Low affinity and lack of curvature of the Michaelis Menten plots precluded reliable determination of kinetic parameters. Catalytic 
efficiencies are from the slope of the initial rates versus substrate concentration. Data are means of a triplicate with standard deviations. 
 
 
Supplementary Table 6. Kinetics of RiAbf43A. 
Substrate KM 
(mM) 
kcat 
(s-1) 
kcat/KM 
(s-1 mM-1) 
    
AX4 0.8 ± 0.1 20 ± 1 25 
 KM 
(mg mL-1) 
kcat 
(s-1) 
kcat/KM 
(mL mg s-1) 
    
WAX 6.3 ± 0.4 12 ± 0 1.9 
Data are means of a triplicate with standard deviations. 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 7. Kinetics RiXyl3A. 
Substrate KM 
(mM) 
kcat 
(s-1) 
kcat/KM 
(s-1 mM-1) 
X2 2.7  ± 0.4 57 ± 3 21 
X3 3.4  ± 0.3 60 ± 2 18 
X4 2.4 ± 0.4 32 ± 2 13 
X5 2.6 ± 0.5 36 ± 1 14 
X6 2.1 ± 0.2 30 ± 1 15 
Data are means of a triplicate with standard deviations. 
 
 
Supplementary Table 8. Kinetics RiXyl8. 
Substrate KM 
(mg/mL) 
kcat 
(S-1) 
kcat/KM 
(s-1mM-1) 
    
X3 4.8 ± 1.0 1208 ± 124 251.7 
X4 5.1  ± 1.5 892  ± 131 174.9 
Data are means of a triplicate with standard deviations. 
 
 
Supplementary Table 9. Deacetylation activity of RiAXE on 
acetylated xylans and aryl acetate. 
Substrate Enzyme(s) 
V 
(µM s.1) 
V/[E] 
(s.1) 
AcBGX RiAXE 2.5 39.1 
 RiAXE+RiXyn10A 3.2 50 
 RiAXE+RiXyn10A+RiAgu115A 2.8 43.8 
    
AcSpruce mannan RiAXE 0.2 3.1 
pNP-acetate RiAXE 4.7a± 0.1 n.d. 
Autolysis  0.07 n.d. 
V: rate, V/[E]: normalized rate by enzyme concentration estimated from NMR 
experiments. aThe activity on paranitrophenyl acetate (pNP-acetate) is 
expressed in U mg-1. 
 
 
Supplementary Table 10. Assignment of chemical shifts for xylan deacetylation by RiAXE. 
 
Structural unit Assignment 
 H-1; C-1 H-2; C-2 H-3; C-3 H-4; C-4 H-5; C-5 H-6; C-6 Ac-H; C 
X 4.42; 105.4 3.19; 75.4 3.53; 76.4 3.78; 79,2 n.d n.d - 
C2 4.68; 102.6 4.69; 76.1 3.79; 74.2 3.86; 78.9 n.d n.d 2.10; 23.1 
/2.16; 23.1 
C3 4.47; 104.3 3.37; 75.4 4.89; 79.9 3.78; 79.1 n.d n.d 2.17;23.2 
C23 4.81; 102.2 4.81; 74.2 5.17; 74.1 4.05; 77.9 n.d n.d (2) 2.10; 22.9/ 
(2)2.12; 23.0 
C3MeGlcA 4.57; 104.2 3.48; 73.6 4.98; 78.1 3.94;78.1 n.d n.d 2.15; 23.3 
MeGlcA 5.17; 96.6 3.56; 74.4 3.53; 73.3 n.d n.d n.d - 
 5.18; 94.8 3.56;74.2 3.53;73.7 n.d n.d n.d - 
 4.56; 99.3 3.25;76.7 3.52;77.9 3.72;79.7 n.d n.d - 
 
 
 
 
 
Supplementary Table 11. Esterase activity for RiAXE measured using MALDI-TOF. 
       
 AcBGX AcAspen 
xylan 
AcSpruce 
mannan 
Cellulose 
mono acetate 
AcChitin InWAX 
       
RiAXE ++ ++ + + - - 
RiAXE + RiAgu115A +++ n.d. n.d. n.d. n.d. n.d. 
+++: complete deacetylation, ++:almost complete acetylation (1 ≥ acetyl/oligosaccharide),  
+: minor deactylation (1-2 acetyl/oligosaccharide), -: no deacetylation). Experiments performed twice. 
 
 
 
Supplementary Table 12. Xylan hydrolysis kinetics of RiXyn10B.  
Substrate 
KM 
(mg mL-1) 
kcat 
(s-1) 
kcat/KM 
(mL mg-1 s-1) 
 
BGX 
 
n.d. 
 
n.d. 
 
9.8 
WAX 4.4 ± 0.8 413 ± 32 94 
InWAX n.d. n.d. 2.3 
n.d.: Low affinity and lack of curvature of the Michaelis Menten plots precluded reliable determination of the kinetic parameters and the catalytic efficiencies are 
determined from the slope of the initial rate data versus substrate concentration. Data are reported as means of triplicates with standard deviations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 13. Cloning and mutagenesis primersa,b. 
Gene Accession 
number 
Name Orientation Sequence (5' -> 3') 
ROSINTL182_ 06494 (AA27-1356) EEV01588.1 RiXyn10A Forward TTTCAGGGCGCCATGGGGGTAAAAAAAGTTTTTACTGCAGAT 
ROSINTL182_ 06494 (AA27-1356) EEV01588.1 RiXyn10A Reverse GACGGAGCTCGAATTTTACTACTTACTGATCTTTATCTTCTTTGCA  
ROSINTL182_ 06494 (AA156-1356) EEV01588.1 RiXyn10A∆CBMx Forward TTTCAGGGCGCCATGGCAGGAGCAGGCGATGCA  
ROSINTL182_ 06494 (AA156-1356) EEV01588.1 RiXyn10A∆CBMx Reverse GACGGAGCTCGAATTTTACTACTTACTGATCTTTATCTTCTTTGCA  
ROSINTL182_ 06494 (AA349-754) EEV01588.1 RiXyn10A-cata Forward TTTCAGGGCGCCATGTCTATTGAGAAGGACATCCCGGA  
ROSINTL182_ 06494 (AA349-754) EEV01588.1 RiXyn10A-cata Reverse GACGGAGCTCGAATTTTAGGATGCATCTACATACGCCCA  
ROSINTL182_ 06494 (AA27-165) EEV01588.1 RiXyn10A-CBMx Forward TTTCAGGGCGCCATGGGGGTAAAAAAAGTTTTTACTGCAGAT  
ROSINTL182_ 06494 (AA27-165) EEV01588.1 RiXyn10A-CBMx Reverse GACGGAGCTCGAATTTTAATCCCCCAATTTTGCA  
ROSINTL182_ 08193 EEU99940.1 RiAbf43A Forward AGGAGATATACCATGAGTATAGCAAAGAATCCGGTTC  
ROSINTL182_ 08193 EEU99940.1 RiAbf43A Reverse GGTGGTGGTGCTCGAAACCCGGTATTCCCTCATA  
ROSINTL182_ 08194 EEU99941.1 RIAXE Forward AGGAGATATACCATGAGTGGACCTGTGGCA  
ROSINTL182_ 08194 EEU99941.1 RIAXE Reverse GGTGGTGGTGCTCGAATTCCACATAGCCAAAACCAA  
ROSINTL182_ 08195 EEU99942.1 RiAgu115A Forward TTTCAGGGCGCCATGGAAGCAATTTTGGTAAAGGATC   
ROSINTL182_ 08195 EEU99942.1 RiAgu115A Reverse GACGGAGCTCGAATTTTATCATCTGTTCGTCCTCCTT  
ROSINTL182_ 08196 EEU99943.1 RiXyl8 Forward AGGAGATATACCATGAAAAGAGGAGCGTTTGAGA  
ROSINTL182_ 08196 EEU99943.1 RiXyl8 Reverse GGTGGTGGTGCTCGAAATAAATTCTATAATTGCCGCTCAG  
ROSINTL182_ 08199 EEU99894.1 RiXBP Forward TTTCAGGGCGCCATGGGAAACAAAGCAGCCG  
ROSINTL182_ 08199 EEU99894.1 RiXBP Reverse GACGGAGCTCGAATTTTATTACTGATATTTTTTTGCTTCCTC  
ROSINTL182_ 08202 EEU99897.1 RiXyl3A Forward AGGAGATATACCATGGAATTAAATCAGAATACAGAAAAACTG  
ROSINTL182_ 08202 EEU99897.1 RiXyl3A Reverse GGTGGTGGTGCTCGAATAACATCAGACTTTCCACTGTTT 
ROSINTL182_06338/ 
ROSINTL182_06339 
EEV01752.1/ 
EEV01731.1 
RiXyn10B Forward TTTCAGGGCGCCATGGCTGGGCAGGAAAATG  
ROSINTL182_06338/ 
ROSINTL182_06339 
EEV01752.1/ 
EEV01731.1 
RiXyn10B Reverse GACGGAGCTCGAATTTTACTATTTATCAGAATGAAATAAATTTTCAA  
aBold nucleotides indicate the sequences annealing to the vector. 
bUnderlined nucleotides indicate the changed codon and italics indicate the changed bases. 
 
 
Supplementary Table 14. qPCR primers use. 
Target bacteria Orientation Sequence (5' -> 3') Reference 
 
Roseburia spp. 
 
Forward 
 
TACTGCATTGGAAACTGTCG  
 
1 
Roseburia spp Reverse CGGCACCGAAGAGCAAT 1 
Bacteroides spp. Forward CGATGGATAGGGGTTCTGAGAGGA 2 
Bacteroides spp. Reverse GCTGGCACGGAGTTAGCCGA 2 
Universal primer Forward ACTCCTACGGGAGGCAGCAGT 3 
Universal primer Reverse GTATTACCGCGGCTGCTGGCAC  3 
1. Larsen, N. et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. 
PLoS One 5, e9085 (2010). 
2. Bergström, A. et al. Introducing GUt Low-Density Array (GULDA)-a validated approach for qPCR-based 
intestinal microbial community analysis. FEMS Microbiol. Lett.337, 38–47 (2012). 
3. Walter, J. et al. Detection and identification of gastrointestinal Lactobacillus species by using denaturing 
gradient gel electrophoresis and species-specific PCR primers. Appl. Environ. Microbiol.66,297–303 (2000). 
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05035 -0.79 5.99 5.44 No PP ABC transporter, permease protein
05036 -0.80 6.04 5.26 No PP ABC transporter, permease protein
05037+05106 -0.33 6.44 5.95 Yes NHL repeat protein
05107 -1.48 5.98 5.53 No Hypothetical protein
05108 -0.42 5.91 5.48 No Hypothetical protein
05109 -0.61 5.87 4.92 No PP ABC transporter, permease protein
05110 -0.63 5.11 3.92 No PP ABC transporter, permease protein
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06331 -0.63 5.26 4.76 No GH43 β-xylosidase/α-L-arabinofuranosidase
06332 -1.60 5.46 4.74 No GH43 β-xylosidase/α-L-arabinofuranosidase
06333 -0.70 0.44 2.24 No AraC Transcriptional regulator
06334 -1.22 1.03 2.44 No GH27 α-galactosidase/β-L-arabinopyranosidase
06335 -0.69 3.58 3.44 No GH43 β-xylosidase/α-L-arabinofuranosidase
06336 -1.04 3.61 3.21 No GH95 α-L-galactosidase/α-L-fucosidase
06337 -0.57 3.45 4.08 No GH43 β-xylosidase/α-L-arabinofuranosidase
06338+06339 -0.99 3.47 3.62 Yes RiXyn10B Endo-1,4-β-xylanase
06341 -1.12 4.09 3.80 No GH43 β-xylosidase/α-L-arabinofuranosidase
06342 -1.32 4.28 4.07 No CE1 Esterase
06343 -1.23 4.49 4.21 Yes GH43 β-xylosidase/α-L-arabinofuranosidase
06344+06345 -1.57 4.49 4.68 No ABC-NBD ABC transporter, nucleotide binding domain
06346 -2.45 5.12 4.74 No ABC-PP ABC transporter, permerase protein
06347 -2.38 5.49 5.35 No Hypothetical ABC transporter
06348 -1.62 4.52 4.04 No Hypothetical ABC transporter
06349 -0.95 6.49 5.44 No UxuA Mannonate dehydratase
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Supplementary Figure 1 R. intestinalis L1-82 unique xylan upregulated loci. (a) Upregulation of a putative xylan metabolism gene
cluster unique for the R. intestinalis L1-82 strain on xylan. (b) Organization of genes in (a). (c) Second unique R. intestinalis L1-82 gene
cluster upregulated on xylan. (d) Organization of putative xylan-metabolism genes upregulated in (c). (e) Fluorescence microscopy of R.
intestinalis grown on xylan showing the extracellular localization of RiXyn10B. Experiments were performed three times and locus IDs
ROSINTL182_xxxxx are abbreviated with the last numbers after the hyphen. Signal peptides (SP) were predicted using SignalP v.3.0.
Genes residing between two contigs have two locus IDs.
a                                                              
b
Locus ID SP Protein Annotation
WAX/Glc BGX/Glc
08977 9.09 5.79 5.26 Yes XylBP ABC transporter, solute-binding protein
08976+06802+06803 8.98 6.15 5.65 No XylNBD ABC transporter, nucleotide binding domain
06804 8.73 5.56 4.43 No XylPP ABC transporter, permease protein
06805 8.42 5.50 4.75 No XylPP ABC transporter, permease protein
08058 5.51 4.34 4.16 No XylA Xylose isomerase
08060 5.05 4.28 3.77 No XylB Xylulokinase
08023 -0.66 5.89 3.11 No AraA L-arabinose isomerase
08024 -0.44 5.55 2.90 No AraK L-ribulokinase
08017 4.40 5.06 4.96 No AraD L-ribulose-5-phosphate 4-epimerase
05880 0.70 0.58 0.59 No UxaC Glucuronate isomerase
06618+06619 0.18 -0.24 5.77 No UxuB Mannonate oxidoreductase
06622 -1.06 1.11 4.06 No UxuA Mannonate dehydratase
05688 -0.18 -0.69 1.26 No KdgK 2-keto-3-deoxy-D-gluconate kinase
05375 -0.61 -0.86 1.26 No KdgA 2-dehydro-3-deoxy phosphogluconate aldolase
06244 6.80 7.15 5.93 No tkt D-xylulose 5-phosphate/D-fructose 6-phosphate phosphoketolase
08021 5.29 5.72 4.85 No tal Fucose isomerase
08020 4.33 4.75 4.37 No tkt Transketolase
08019 4.06 4.44 3.76 No tkt Transketolase
08018 4.19 4.65 4.47 No tkt Transketolase
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Supplementary Figure 2 R. intestinalis L1-82 xylose metabolism. (a) Proposed model for the metabolism of the monosaccharides
xylose, arabinose and glucuronic acid in R. intestinalis L1-82 based on the RNA-seq data in Supplementary Table 1, and literature. (b)
Upregulation of xylose import and metabolism genes in the model. The RNA-Seq heatmap depicts Log2-fold changes of genes expressed
by cells grown on xylose (X1), wheat arabinoxylan (WAX) and birch glucuronoxylan (BGX) relative to glucose (Glc). Locus numbers
ROSINTL182_xxxxx are abbreviated with the last numbers after the hyphen.
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Supplementary Figure 3 Conservation of R. intestinalis core xylan utilization genes within the Roseburia genus. Genes are denoted
according to their protein products; glycoside hydrolase (GH), carbohydrate esterase (CE), transcriptional regulators (Trans.R.), ABC
transporter solute binding protein (SBP), ABC transporter permease protein (PP) and hypothetical proteins (Hypothe.). Sequence
identities to R. intestinalis L1-82 genes are shown above the genes; Locus IDs for the genes are denoted under the respective strains.
The asterisk indicates that the GH10 is not assigned in the genome.
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Supplementary Figure 4 Properties of the extracellular xylanases from R. intestinalis (a) Action patterns of RiXyn10A on X2−X5 
analyzed by TLC; +: reaction with enzyme, -: controls without enzyme. The dotted line indicates that lanes not relevant to the figure 
were spliced out for clarity. (b-g) Hydrolysis kinetics of RiXyn10A, RiXyn10A∆CBMx lacking the N-terminal module and RiXyn10A-cata, 
the catalytic module on WAX, and BGX. (h) Binding of xylans to RiXyn10-CBMx by affinity gel electrophoresis using native 
polyacrylamide gels with different concentrations of WAX (0.0-0.1% w/v) or BGX (0.0-1.0% w/v). No polysaccharides were added to the 
control. Lane 1+2; RiXyn10A-CBMx (3.0 µg), Lane 3 β-lactoglobulin (1.5 µg), M; marker. (i) Domain organization of the xylanase 
RiXyn10B encoded by a locus upregulated on xylan and which is unique for the R. intestinalis L1-82 strain used in the present study 
(Supplementary Fig. 1c-d). The bottom cartoon represents the recombinant enzyme. Experiments in (a) and (h) are performed twice and 
in triplicates for (b-g). 
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RiXyn10A-CBMx, [X6]
Supplementary Figure 5 Binding of CBMx and RiXyn10A to xylo-oligosaccharides. (a-e) Reference and blank corrected sensograms
depict binding of xylo-oligosaccharides (X3-X6) and mannohexaose (Man6) as negative control to CBMx (RiXyn10A-CBMx) using SPR
analysis. (f) ITC analysis of CBMx binding to X6. (g,i) Reference and blank corrected SPR sensograms depicting the binding of X6 to
RiXyn10A and RiXyn10A∆CBMx respectively. (h,j) One binding model fitted to the binding isotherms from the sensograms in (g,i). The
experiments were in triplicates, except for the ITC run once.
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Supplementary Figure 6 Binding preference of RiXBP associated to the xylo-oligomer ABC transporter of R. intestinalis. (a-g) ITC
analysis of RiXBP binding to linear and branched xylo-oligosaccharides. (h,i) Structures of the branched arabinosylated xylo-
oligosaccharides AX4 and AX3, which are mixtures with arabinofuranosyl decoration either at the C2 or C3 of xylosyl units. (j,k) Time
course HPAEC-PAD analysis of culture supernatants of R. intestinalis grown in YCFA with 0.5% WAX or BGX. The observed peaks
between 0 and 5 minutes are likely unutilized medium components. Experiments in (a-g) are duplicates, and in (j,K) from a duplicate.
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Supplementary Figure 7 Intracellular xylo-oligosaccharide degrading enzymes from R. intestinalis (a) TLC analysis of the release of 4-
O-methylglucuronic acid (MeGlcA) from BGX and BeGX by RiAgu115A. Glucuronic acid (GlcA) is used as standard. (b,c) Activity of 
RiAgu115A on a GH30-hydrolyzed BeBGX monitored using MALDI-ToF MS; (b) is the GH30 control and (c) is the treatment with GH30 
and RiAgu115A.  Activity indicates RiAgu115A releases MeGlcA from the penultimate xyloxyl to the reducing end in xylo-
oligosaccharides based on the GH30 strict specificity1, whereas a GH10 generates xylo-oligosaccharides with a MeGlcA substitution at 
the non-reducing end2. This data shows that the RiAgu115A is able to act on both internal and terminal non-reducing end substitutions 
on glucuronoxylan-derived xylo-oligosaccharides. Di-sodium adducts of MeGlcA decorated oligomers (diamonds) are colored as their 
corresponding single sodium adducts. (d,g) Monosaccharide hydrolysis products from enzymatic treatment of WAX and BGX with 
RiXyn10A, RiAbf43A, RiXyl3A and RiXyl8 by HPAEC-PAD. Standards were 1; arabinose, 2; galactose, 3; glucose, 4; xylose. (e,f) RiXyl3A 
and RiXyl8 hydrolysis of xylo-oligosaccharides analyzed with HPAEC-PAD. (h) β-Xylosidase activity for RiXyl3A and RiXyl8 towards xylo-
oligosaccharides (XOS) by TLC. The + and - indicate the presence and absence of the different components, respectively. Lack of activity 
on substrate reduced with NaBH4 (converts reducing end unit to its alditol) provided evidence that RiXyl8 acts on the reducing end as 
the alditol is not accommodated in the active site. Experiments are performed in duplicates. 
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Supplementary Figure 8 Activity, specificity and taxonomic distribution of the novel xylan acetyl esterase RiAXE. (a) Phylogenetic tree 
of RiAXE and homologs identified by a BLASTP search against the non-redundant database. Sequences with coverage >86% and identity 
>42% were selected. All sequences were from Firmicutes members. The resulting 131 protein sequences were aligned using Muscle1 
and a phylogenetic tree constructed by the maximum likelihood algorithm in MEGA72. Bootstraps were performed with 500 replicates. 
The phylogenetic tree was visualized using Figtree (http://tree.bio.ed.ac.uk/software/figtree). Asterisk indicates position of RiAXE. (b) 
Time course deacetylation of AcBGX treated with RiXyn10A and RiAgu115A by RiAXE determined by NMR. (c) Rates of deacetylation by 
RiAXE on AcBGX and AcSpruce mannan (AcSGGM) in D2O, which may influence absolute reaction rates. (d) 
13C HSQC spectrum of 
RiXyn10A treated AcBGX showing the acetyl region and with the 1D proton projection. (e)  same as (d) but showing the spectral region 
for anomeric and O-acetylated xylose signals. RiXyn10a treatment enhances signal-to-noise of resonances in the NMR spectra for the 
assignment and increases the total number of observable individual signals. (f,g) 13C HSQC spectra for O-acetylated regions before (f) 
and after (g) deactylation by RiAXE. Nearly complete deacetylation of AcBGX is reached during the time resolved NMR experiment. 
Chemical shifts of the most dominating signal for the monosaccharide residues mark by “+”, peaks encircled by dotted lines indicate 
cluster of chemical shifts likely to belong to the same type of monosaccharide residue as dominating signal. 
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Supplementary Figure 9 Co-culture experiment with R. intestinalis and B. ovatus. (a-b) Growth curves for monoculture and co-cultures
after growth of R. intestinalis and B. ovatus with water as controls instead of carbon source. (c) Relative abundance determined by qPCR
in a propagation experiment with co-cultures on WAX. After 9 hours of growth, the co-culture was passaged into fresh media, passage
(I) (start OD600 nm=0.01). This culture was grown for 12 hours and passaged into fresh media again (passage II). The western blots were
carried out with (d) anti-RiXBP, (e) anti-RiXyn10A, (f) anti-RiXyn10B. R: R. intestinalis, B: B. ovatus, C: co-culture of R. intestinalis and B.
ovatus. Asterisk denotes the position of the band based on theoretical molecular mass. The molecular markers size is shown in kDa.
Lower molecular mass signals than expected indicate proteolytic cleavage occurring particularly with the multi-modular RiXyn10A.
Experiments are performed in biological triplicates in (a-c) and in duplicates in (d-f).
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